Biotech | February 18, 2022
USFDA clears Kairos Pharma’s IND to treat prostrate cancer
Phase 2 clinical trial to begin in 2022 with participation by Cedars Sinai Medical Center, University of Utah, and City of Hope
Phase 2 clinical trial to begin in 2022 with participation by Cedars Sinai Medical Center, University of Utah, and City of Hope
The tele-heath market in India is expected to touch US $ 5.4 billion by 2025 and the adoption of tele-health has accelerated with the onset of Covid-19 in 2020. We caught up with Jeya Kumar, Founder and MD, RaphaCure, a prominent player in this segment and he outlined the opportunities that lie ahead for this segment
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
Zeebon is the largest diagnostics services provider in North-Eastern states
Sucharita brings with her a rich and varied experience of two decades in Information Technology and Financial Services
After specialising in laparoscopy, proctology, urology, and cosmetic surgeries, Glamyo Health is now venturing into orthopaedic surgeries
The fund aims at investing in companies that extends human healthspan
The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes
The programme will be implemented across 13 states and benefit 256 min
The nutraceutical sector is on the cusp of exponential growth and Covid-19 has accelerated the pace of its applications. Dr R.B Smarta, CMD, Interlink, shares his perspective on the growth opportunities and challenges for the sector
Subscribe To Our Newsletter & Stay Updated
